Early growth response 2 as a target of IL-13/STAT6 signaling induces the goblet cell metaplasia of allergic airway epithelia

Key Points

• The aim is to explore how EGR2 contributes to mucous production in allergic airway conditions.
• Investigated the upregulation of EGR2 expression in allergic airway epithelia
• Analyzed the relationship between EGR2 and goblet cell metaplasia
• Evaluated potential therapeutic interventions targeting EGR2
• EGR2 expression is significantly increased in allergic airway epithelia
• Goblet cell metaplasia and mucous hypersecretion are linked to elevated EGR2 levels
• Intervening EGR2 is suggested as a promising therapeutic approach for asthma-related symptoms